Brookfield Set to Drop Grifols Bid as Family Shuns Others
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.
Brookfield drops US$6.8-billion offer to buy drugmaker Grifols
Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb. 29. They traded eight per cent lower at 3 p.m. in Madrid. Its bonds due in October 2028 recorded the steepest daily drop since January in early morning trading to around 89 cents.
The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...
Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management has withdrawn its plan to acquire it. Both parties likely failed to ...
Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over ...
The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...
Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...
The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...
Brookfield Asset Management Ltd. abandonó los planes de adquirir Grifols SA, poniendo fin a meses de negociaciones para ...
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback